发明名称 3′,5′-cyclic phosphoramidate prodrugs for HCV infection
摘要 Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents.
申请公布号 US9109001(B2) 申请公布日期 2015.08.18
申请号 US201313899257 申请日期 2013.05.21
申请人 IDENIX PHARMACEUTICALS, INC. 发明人 Parsy Christophe Claude;Alexandre Francois-Rene;Dousson Cyril B.;Dukhan David;Pierra Claire;Surleraux Dominique;Mayes Benjamin Alexander;Moussa Adel M.;Stewart Alistair James
分类号 A61K31/70;C07H19/20;A61K31/7076;A61K45/06;C07H19/11 主分类号 A61K31/70
代理机构 Squire Patton Boggs (US) 代理人 Squire Patton Boggs (US)
主权项 1. A compound of Formula I:or a pharmaceutically acceptable salt, solvate, stereoisomeric form, tautomeric form, or polymorphic form thereof, wherein: X is alkoxyl, hydrogen, or hydroxyl; Y is hydroxyl, acetoxyl, or fluoro; Z is substituted alkyl; LC(O)O(L)pC(R)3, -LOC(O)(L)pC(R)3, -LC(O)O(L)pCy, -L-S—S-(LpC(R)3, -LSC(O)(L)pC(R)3, L-S—S-(L)pC(R)3, or -LSC(O)(L)pC(R)3; each L is independently unsubstituted alkylene or substituted alkylene; Cy is unsubstituted cycloalkyl; and p is 0 or 1; and R is hydrogen, alkyl, substituted alkyl, unsubstituted cycloalkyl, unsubstituted aryl, substituted aryl, or heteroaryl.
地址 Cambridge MA US